Deloitte has acquired the assets of Intrasphere Technologies, a drug-safety and regulatory consulting business, according to a Deloitte news release.
Deloitte buys Intrasphere
Financial terms of the deal were not disclosed. Intrasphere Technologies, Jersey City, N.J., offers a software program that allows companies to register clinical trial information on government registries.
According to the release, the software program will be offered within the Deloitte Managed Analytics division. Dan Ressler, a principal with Deloitte Consulting LLP, will lead the firm's drug-safety and regulatory consulting business.
"The growing impact of health information technology and social media, greater complexity of therapeutic offerings in the marketplace and an increasingly complex and stringent regulatory environment, in particular, have created an impetus for more proactive product safety and regulatory support services," Ressler said in the release.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.